...
首页> 外文期刊>Pediatric dermatology >Skin cleansing and topical product use in patients with epidermolysis bullosa: Results from a multicenter database
【24h】

Skin cleansing and topical product use in patients with epidermolysis bullosa: Results from a multicenter database

机译:皮肤清洁和局部产品用于表皮渗透Bullosa的患者:多中心数据库的结果

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Background/Objectives Epidermolysis bullosa (EB) comprises a group of inherited skin blistering diseases. There is currently no cure, and management includes skin protection and prevention of infection. To date, there has been no systematic investigation of home skin care practices among EB patients on a multicenter scale. Methods This cross‐sectional, observational study included data collected from patients with EB enrolled in the Epidermolysis Bullosa Characterization and Clinical Outcomes Database (EBCCOD) who provided answers to a patient‐directed questionnaire between January 1, 2017, and December 31, 2017. Results Of 202 respondents, 130 (64.4%) had dystrophic EB, 51 (25.2%) had EB simplex, 21 (7.4%) had junctional EB, 3 (1.5%) had Kindler syndrome, and 3 (1.5%) had an unspecified subtype. Seventy‐eight patients reported cleansing in plain water only (39%). Of those who used an additive in their cleansing water, 75 (57%) added salt, 71 (54%) added bleach, 36 (27%) added vinegar, and 34 (26%) endorsed the use of an “other” additive (multiple additives possible). Reported concentrations of additives ranged widely from 0.002% sodium hypochlorite and 0.002% acetic acid solutions, which are thought to have negligible effects on microbes, to 0.09% sodium hypochlorite and 0.156% acetic acid, concentrations shown to be cytotoxic. One hundred eighty‐eight patients answered questions regarding topical product use (93%). Of those, 131 reported topical antimicrobial use (70%). Mupirocin and bacitracin were the most commonly reported topical antibiotics (59, 58 [31.4%, 30.9%], respectively). Conclusions These findings highlight the variety of skin care routines and frequent use of topical antimicrobials among EB patients and have potential implications for antibiotic resistance. The reported range of bleach and vinegar additives to cleansing water, including cytotoxic concentrations, emphasizes the need for clear and optimized skin cleansing recommendations.
机译:摘要背景/目标表皮溶解Bullosa(EB)包含一群遗传的皮肤起泡疾病。目前没有治愈,管理层包括皮肤保护和预防感染。迄今为止,在多中心规模的EB患者中没有系统调查家庭护肤实践。方法使用这种横截面的观察性研究包括从EB患者收集的数据,注册了表皮神经分解的Bullosa表征和临床结果数据库(EBCCOD),他们为2017年1月1日至2017年12月31日提供了患者定向的问卷。结果在202名受访者中,130名(64.4%)具有营养不良的EB,51(25.2%)具有EB单纯乳头,21例(7.4%)有结eB,3(1.5%)有Kindler综合征,3(1.5%)有一个未指明的亚型。七十八名患者报告仅在普通水中清洁(39%)。在其清洁水中使用添加剂的人的盐,71(57%)加入的盐,36(27%)加入醋,34(26%)辅以使用“其他”添加剂(可能的多种添加剂)。报道的添加剂浓度范围广泛地从0.002%的次氯酸钠和0.002%乙酸溶液中广泛,这被认为对微生物的效果可忽略不计,次数为0.09%次氯酸钠和0.156%乙酸,所示浓度为细胞毒性。一百八十八名患者回答了关于局部产品的问题(93%)。其中,131次报告了局部抗菌剂(70%)。 Mupirocin和Bacitracin是最常见的局部抗生素(59,58分别[31.4%,30.9%])。结论这些发现突出了各种皮肤护理惯例,常常使用EB患者中的局部抗菌剂,对抗生素抗性产生潜在的影响。报告的漂白剂和醋添加剂为清洁水,包括细胞毒性浓度,强调需要清洁和优化的皮肤清洁建议。

著录项

  • 来源
    《Pediatric dermatology》 |2020年第2期|共7页
  • 作者单位

    Columbia University Vagelos College of Physicians and SurgeonsNew York New York;

    Department of DermatologyColumbia University Irving Medical CenterNew York New York;

    Columbia University Vagelos College of Physicians and SurgeonsNew York New York;

    Cincinnati Children's Hospital Medical CenterCincinnati Ohio;

    Departments of Dermatology and PediatricsUniversity of Colorado School of MedicineAurora Colorado;

    Section of DermatologyHospital for Sick ChildrenToronto Ontario Canada;

    Section of DermatologyHospital for Sick ChildrenToronto Ontario Canada;

    Division of DermatologyUniversity of Massachusetts Medical SchoolWorcester Massachusetts;

    CHU Sainte‐JustineUniversity of MontrealMontreal Quebec Canada;

    Departments of Dermatology and PediatricsColumbia University Irving Medical CenterNew York New York;

    Departments of Pediatrics and DermatologyUniversity of California San DiegoSan Diego California;

    Department of DermatologyUniversity of Minnesota Medical SchoolMinneapolis Minnesota;

    Department of Pediatric DermatologyChildren's Hospital San AntonioSan Antonio Texas;

    Department of DermatologyUniversity of Miami Miller School of MedicineMiami Florida;

    Section of Pediatric DermatologyThe Children's Hospital of PhiladelphiaPhiladelphia Pennsylvania;

    Section of Pediatric DermatologyThe Children's Hospital of PhiladelphiaPhiladelphia Pennsylvania;

    Departments of Pediatrics and Medicine (Dermatology)University of TexasAustin Texas;

    Department of DermatologyState University of New York Downstate Medical CenterBrooklyn New York;

    Departments of Dermatology and PediatricsColumbia University Irving Medical CenterNew York New York;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 皮肤病学与性病学;
  • 关键词

    epidermolysis bullosa; genodermatoses; quality of life; skin barrier; therapy‐topical;

    机译:表皮溶解Bullosa;Genodermatose;生活质量;皮肤屏障;治疗 - 局部;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号